CORC

在结果中检索

CORC

浏览/检索结果: 共61条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Design, synthesis, and bioactivity evaluation of novel Bcl-2/HDAC dual-target inhibitors for the treatment of multiple myeloma 期刊论文
Bioorganic & medicinal chemistry letters, 2018
作者:  Zhou, Ruolan;  Fang, Shaoyu;  Zhang, Minmin;  Zhang, Qingsen;  Hu, Jian
收藏  |  浏览/下载：97/0  |  提交时间：2019/01/08
Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy 期刊论文
Journal of Immunotherapy, 2018
作者:  Yi Zhang;  Jianmin Huang;  Ying Zeng;  Hongling Zhang;  Yingjin Qiao
收藏  |  浏览/下载：72/0  |  提交时间：2019/01/31
Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Chang, Lung-Ji;  Li, Yuhua;  Tu, Sanfang;  Lai, Xun;  Huang, Rui
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/04
Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Wang, Lixin;  Chen, Guofeng;  Shen, Jianliang;  Luo, Jianmin;  Fang, Meiyun
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Unmask the genetic backbone of ibrutinib-relapsed chronic lymphocytic leukemia progression and Richter transformation 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 卷号: 6, 期号: 11
作者:  Wang, Wei-Ge;  Zhou, Xiao-Yan;  Li, Xiao-Qiu
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
OLAPARIB MAINTENANCE MONOTHERAPY IMPROVES PROGRESSION-FREE SURVIVAL (PFS) IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER (PSROC): SOLO2 STUDY - CHINA COHORT 会议论文
作者:  Liu, J.;  Yin, R.;  Wu, L.;  Zhu, J.;  Lou, G.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Safety and efficacy of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma from China 会议论文
作者:  Song, Y.;  Hong, X.;  Huang, H.;  Bai, B.;  Zhang, H.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma 会议论文
作者:  Leonard, John P.;  Trneny, Marek;  Izutsu, Koji;  Fowler, Nathan H.;  Hong, Xiaonan
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace